Literature DB >> 22807963

Upper urinary tract inverted papillomas: Report of 10 cases.

Jin-Dan Luo1, Ping Wang, Jun Chen, Ben Liu, Shuo Wang, Bo-Hua Shen, Li-Ping Xie.   

Abstract

The aim of the study was to review the clinical features and treatments of 10 (9 males and 1 female; age range, 61-73 years; median age, 67 years) upper urinary tract inverted papilloma (IP) cases between 1995 and 2010. The clinical syndromes, diagnostic procedures, treatments and results of the follow-up were evaluated. The results showed that the site of tumor development was the ureter in 6 cases and the renal pelvis in 4 cases. It was also identified that 7 tumors developed on the left side and 3 developed on the right side of the ureter and renal pelvis, respectively. A nephroureterectomy was performed in the first 6 cases, while a partial ureterectomy was performed in 3 cases and a local resection was performed endoscopically in 1 case. All but 2 tumors were solitary, ranging from 5 to 30 mm in diameter. Occurrence in association with transitional cell carcinoma was identified in one case. All 10 patients were subject to follow-up (range, 19-120 months; median, 59 months), during which no recurrence was found. Local excision is considered as adequate treatment when upper urinary tract IP is diagnosed according to strictly defined criteria.

Entities:  

Year:  2012        PMID: 22807963      PMCID: PMC3398347          DOI: 10.3892/ol.2012.706

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  INVERTED PAPILLOMA OF THE BLADDER.

Authors:  I F POTTS; E HIRST
Journal:  J Urol       Date:  1963-08       Impact factor: 7.450

2.  Atypia in inverted urothelial papillomas: pathology and prognostic significance.

Authors:  Jennifer N Broussard; Puay Hoon Tan; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2004-12       Impact factor: 3.466

3.  Inverted papilloma: an unusual recurrent, multiple and multifocal lesion.

Authors:  T A Rozanski
Journal:  J Urol       Date:  1996-04       Impact factor: 7.450

Review 4.  The prognostic value of a primary inverted papilloma of the urinary tract.

Authors:  J A Witjes; M R van Balken; C A van de Kaa
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

5.  Is surveillance necessary for inverted papilloma in the urinary bladder and urethra?

Authors:  Chi Wai Cheng; Lung Wai Chan; Chi Kwok Chan; Chi Fai Ng; Ho Yuen Cheung; Shu Yin Eddie Chan; Wai Sang Wong; Ka Fai To
Journal:  ANZ J Surg       Date:  2005-04       Impact factor: 1.872

6.  Inverted papilloma of renal pelvis: flexible ureteroscopic diagnosis and treatment.

Authors:  D H Bagley; P McCue; A S Blackstone
Journal:  Urology       Date:  1990-10       Impact factor: 2.649

Review 7.  Upper urinary tract inverted papillomas.

Authors:  A N Chiura; A Wirtschafter; D H Bagley
Journal:  Urology       Date:  1998-09       Impact factor: 2.649

8.  Histology and histogenesis of two different types of inverted urothelial papillomas.

Authors:  E Kunze; A Schauer; M Schmitt
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

9.  Evaluation of urinary inverted papillomas: a report of 13 cases and literature review.

Authors:  Mete Kilciler; Selahattin Bedir; Fikret Erdemir; Onder Ors; Yusuf Kibar; Murat Dayanc
Journal:  Kaohsiung J Med Sci       Date:  2008-01       Impact factor: 2.744

Review 10.  Inverted papilloma of the upper urinary tract.

Authors:  L Spevack; S Herschorn; J Srigley
Journal:  J Urol       Date:  1995-04       Impact factor: 7.450

View more
  2 in total

1.  Inverted urothelial papilloma of the upper urinary tract: description of two cases with systematic literature review.

Authors:  R Santi; I C Galli; V Canzonieri; J I Lopez; G Nesi
Journal:  Diagn Pathol       Date:  2020-04-22       Impact factor: 2.644

2.  Overactivity or blockade of transforming growth factor-β each generate a specific ureter malformation.

Authors:  Filipa M Lopes; Neil A Roberts; Leo Ah Zeef; Natalie J Gardiner; Adrian S Woolf
Journal:  J Pathol       Date:  2019-10-01       Impact factor: 7.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.